HMBD-001 is Hummingbird Bioscience’s proprietary anti-HER3 antibody in Phase I/IIa trials in the UK and Phase Ib trials in Australia, targeting multiple solid tumors The clinical data shows that HMBD-001 is safe and well-tolerated with no dose-limiting toxicities and no severe…